BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31451388)

  • 1. Emerging challenges of whole-genome-sequencing-powered epidemiological surveillance of globally distributed clonal groups of bacterial infections, giving Acinetobacter baumannii ST195 as an example.
    Jia H; Chen Y; Wang J; Xie X; Ruan Z
    Int J Med Microbiol; 2019 Nov; 309(7):151339. PubMed ID: 31451388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs.
    Hammerum AM; Hansen F; Skov MN; Stegger M; Andersen PS; Holm A; Jakobsen L; Justesen US
    J Antimicrob Chemother; 2015 Jul; 70(7):1965-8. PubMed ID: 25795772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections.
    Chen T; Fu Y; Hua X; Xu Q; Lan P; Jiang Y; Yu Y; Zhou Z
    Int J Antimicrob Agents; 2021 Oct; 58(4):106404. PubMed ID: 34298091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous emergence and rapid spread of three OXA-23 producing Acinetobacter baumannii ST208 strains in intensive care units confirmed by whole genome sequencing.
    Chen Q; Zhou JW; Fan JZ; Wu SH; Xu LH; Jiang Y; Ruan Z; Yu YS; Yu DJ; Wang XJ
    Infect Genet Evol; 2018 Mar; 58():243-250. PubMed ID: 29320720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year molecular surveillance of carbapenem-susceptible
    Wendel AF; Malecki M; Otchwemah R; Tellez-Castillo CJ; Sakka SG; Mattner F
    Antimicrob Resist Infect Control; 2018; 7():145. PubMed ID: 30505434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.
    Shrestha S; Tada T; Miyoshi-Akiyama T; Ohara H; Shimada K; Satou K; Teruya K; Nakano K; Shiroma A; Sherchand JB; Rijal BP; Hirano T; Kirikae T; Pokhrel BM
    Int J Antimicrob Agents; 2015 Nov; 46(5):526-31. PubMed ID: 26362951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexplored Genetic Diversity of Multidrug- and Extremely Drug-Resistant
    López-Leal G; Zuniga-Moya JC; Castro-Jaimes S; Graña-Miraglia L; Pérez-Oseguera Á; Reyes-García HS; Gough-Coto SD; Pavón-Madrid R; Bejarano SA; Ferrera A; Castillo-Ramírez S; Cevallos MA
    Microb Drug Resist; 2019 Jun; 25(5):690-695. PubMed ID: 30614762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital Outbreaks.
    Fitzpatrick MA; Ozer EA; Hauser AR
    J Clin Microbiol; 2016 Mar; 54(3):593-612. PubMed ID: 26699703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii.
    Hahm C; Chung HS; Lee M
    PLoS One; 2022; 17(3):e0264335. PubMed ID: 35245298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics.
    Bian X; Liu X; Zhang X; Li X; Zhang J; Zheng H; Song S; Li X; Feng M
    BMC Genomics; 2021 Jul; 22(1):530. PubMed ID: 34247587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin, Phylogeny, and Transmission of the Epidemic Clone ST208 of Carbapenem-Resistant Acinetobacter baumannii on a Global Scale.
    Gao Y; Li H; Chen H; Zhang J; Wang R; Wang Z; Wang H
    Microbiol Spectr; 2022 Jun; 10(3):e0260421. PubMed ID: 35638783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.
    Meumann EM; Anstey NM; Currie BJ; Piera KA; Kenyon JJ; Hall RM; Davis JS; Sarovich DS
    Microb Genom; 2019 Mar; 5(3):. PubMed ID: 30806611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.
    Wright MS; Haft DH; Harkins DM; Perez F; Hujer KM; Bajaksouzian S; Benard MF; Jacobs MR; Bonomo RA; Adams MD
    mBio; 2014 Jan; 5(1):e00963-13. PubMed ID: 24449752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of a Carbapenemase-producing
    Bogaty C; Mataseje L; Gray A; Lefebvre B; Lévesque S; Mulvey M; Longtin Y
    Antimicrob Resist Infect Control; 2018; 7():140. PubMed ID: 30479753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SISPA-Seq for rapid whole genome surveys of bacterial isolates.
    Wright MS; Stockwell TB; Beck E; Busam DA; Bajaksouzian S; Jacobs MR; Bonomo RA; Adams MD
    Infect Genet Evol; 2015 Jun; 32():191-8. PubMed ID: 25796360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme.
    Wisplinghoff H; Hippler C; Bartual SG; Haefs C; Stefanik D; Higgins PG; Seifert H
    Clin Microbiol Infect; 2008 Jul; 14(7):708-15. PubMed ID: 18558944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination.
    Ying C; Li Y; Wang Y; Zheng B; Yang C
    J Antibiot (Tokyo); 2015 Sep; 68(9):562-7. PubMed ID: 25873322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.